← Leaderboards
Gokul M Das
University Of Texas Hlth Sci Ctr San Ant
$4,386,805
Attributed
$4,915,990
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $599.3K · FY2009–25$1M$750K$500K$250K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,915,990 · 4
By mechanism
R01$3,857,619 · 2
R21$1,058,371 · 2
Top collaborators
- Swati Kulkarni2 shared
- Keshav K. Singh2 shared
Most similar at University Of Texas Hlth Sci Ctr San Ant
Same institution · by research overlap
- Kenneth M Hargreaves$34,502,152
- William P Clarke$10,604,907
- Peter John Hart$4,421,670
- Robert G Brzyski$1,737,355
Others in their field
Top investigators on “Neoplastic Cell”
- David Heimbrook · Leidos Biomedical Research, Inc.$139,710,838
- Gregory H Reaman · National Childhood Cancer Foundation$31,993,642
- Bruce W Stillman · Cold Spring Harbor Laboratory$25,455,900
- Ralph Parchment · Leidos Biomedical Research, Inc.$25,266,647
- Andrea Califano · Columbia University Health Sciences$22,374,316
- Wendell A Lim · University Of California, San Francisco$22,334,734
Research focus
Neoplastic CellEstrogen ReceptorsResponseReportingInnovationAffectTp53 GeneSignal TransductionPreventionTumor Suppressor ProteinsProteinsBreast Cancer CellMalignant Breast NeoplasmMalignant NeoplasmsApoptosisLeadEstrogensMediatingArchivesLinkResistanceIn VivoPropertyCells
Grant awards (14)
Functional Significance of individual p53 mutations in determining the role of estrogen receptor beta in triple negative breast cancer$557,448
R01 · FY2025 · CA · contact PI
Functional Significance of individual p53 mutations in determining the role of estrogen receptor beta in triple negative breast cancer$579,696
R01 · FY2024 · CA · contact PI
Functional Significance of individual p53 mutations in determining the role of estrogen receptor beta in triple negative breast cancer$591,642
R01 · FY2023 · CA · contact PI
Functional Significance of individual p53 mutations in determining the role of estrogen receptor beta in triple negative breast cancer$599,304
R01 · FY2022 · CA · contact PI
Functional Significance of individual p53 mutations in determining the role of estrogen receptor beta in triple negative breast cancer$566,906
R01 · FY2021 · CA · contact PI
Therapeutic implication of estrogen receptor-p53 interaction in mitochondria$189,872
R21 · FY2013 · CA · contact PI
Therapeutic implication of estrogen receptor-p53 interaction in mitochondria$221,025
R21 · FY2012 · CA · contact PI
Role of Estrogen Receptor alpha-p53 Interaction in Resistance to Tamoxifen Therap$325,629
R21 · FY2010 · CA · contact PI
Role of Estrogen Receptor alpha-p53 Interaction in Resistance to Tamoxifen Therap$321,845
R21 · FY2009 · CA · contact PI
P53 AND ESTROGEN IN PCNA EXPRESSION OSTEOSARCOMA CELLS$286,449
R01 · FY2003 · CA
P53 AND ESTROGEN IN PCNA EXPRESSION OSTEOSARCOMA CELLS$234,878
R01 · FY2002 · CA
P53 AND ESTROGEN IN PCNA EXPRESSION OSTEOSARCOMA CELLS$16,481
R01 · FY2002 · CA
P53 AND ESTROGEN IN PCNA EXPRESSION OSTEOSARCOMA CELLS$215,547
R01 · FY2001 · CA
P53 AND ESTROGEN IN PCNA EXPRESSION OSTEOSARCOMA CELLS$209,268
R01 · FY2000 · CA